John Pagel, M.D., Ph.D., Actinium Advisory Board Member, to Discuss Bone Marrow Transplant as a Treatment Option for Patients With AML Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) ("Actinium" or ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A hematologist in Italy shared his personal experience addressing the intersection of COVID-19 and ...
Bionano announced a significant study published in the American Journal of Hematology demonstrating the utility of optical genome mapping (OGM) in detecting structural variants associated with ...
NEW YORK, NY--(Marketwired - June 15, 2016) - Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) Webinar to Be Held on Friday, June 17, 2016 Featuring Thought Leaders in the Field of AML John Pagel, M.D.